Sfoglia per Autore
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified.
2009 Gazzola A; Bertuzzi C; Agostinelli C; Righi S; Pileri SA; Piccaluga PP.
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
2009 Piccaluga PP; Sabattini E; Bacci F; Agostinelli C; Righi S; Salmi F; Testoni N; Paolini S; Castagnetti F; Martinelli G; Falini B; Pileri SA.
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment.
2009 Piccaluga P.P.; Rossi M.; De Falco G.; Esposito A.; Tazzari P.L.; Ricci F.; Agostinelli C.; Righi S.; Gazzola A.; Went P.; Alviano F.; Luzzi A.; Morettini F.; Bagnara G.P.; Lazi S.; Zinzani P.L.; Lorenzo L.; Pileri S.A.
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified
2010 Gazzola A.; Sista M.T.; Agostinelli C.; Righi S.; Sapienza M.R.; Mannu C.; Rossi M.; Bacci F.; SAbattini E.; Went P.; Zinzani P.L.; Pileri S.A.; Piccaluga P.P.
Chronic inflammation, including Autoimmunity, and Lymphomagenesis.
2010 Pileri S.A.; Agostinelli C.; Campidelli C.; Bacci F.; Sabattini E.; Giunti M.; Pileri A. Jr.; Piccioli M.; Righi S.; Rossi M.; Ferri C.; Piccaluga P.P.
Prognostic markers in peripheral T-cell lymphoma.
2010 Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA.
Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.
2010 Tripodo C; Gri G; Piccaluga PP; Frossi B; Guarnotta C; Piconese S; Franco G; Vetri V; Pucillo CE; Florena AM; Colombo MP; Pileri SA.
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
2010 Visani G; Breccia M; Gozzini A; Specchia G; Montefusco E; Morra E; Annunziata M; Camera A; Cavazzini F; Stagno F; Pregno P; Usala E; Santini V; Piccaluga PP; Isidori A.
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples.
2010 Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Marafioti T; Bettini G; Falini B; Pileri SA.
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified.
2010 Piccaluga P.P.; Agostinelli C.; Gazzola A.; Sista M.T.; Righi S.; Bacci F.; Sabattini E.; Rossi M.; Mannu C.; Went P.; Zinzani P.L.; Pileri S.A.
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience.
2010 Mannu C.; Sagramoso C.; Gazzola A.; Rossi M.; Sapienza M.R.; La ginestra A.; Bacci F.; Sabattini E.; Agostinelli C.; Artioli P.; Chili L.; Da Pozzo G.; Piccioli M.; Righi S.; Sandri F.; Pileri S.A.; Piccaluga P.P.
LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms.
2010 Agostinelli C.; Patterson J.C.; Gupta R.; Righi S.; Sandri F.; Piccaluga P.P.; Bacci F.; Sabattini E.; Pileri S.A.; Marafioti T.
Pathobiology of Hodgkin Lymphoma.
2010 P. Piccaluga; SA. Pileri.
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES
2010 M. Ciccone; C. Agostinelli; G. Rigolin; L. Rizzotto; F. Cavazzini; S. Righi; M.T. Sista; E. Sabattini; O. Sofritti; P.P. Piccaluga; A. Cuneo; S. Pileri; P.L. Zinzani; M. Brugiatelli; I. Attolico; G. Fioritono; C. Stilitano
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.
2010 Piva R; Agnelli L; Pellegrino E; Todoerti K; Grosso V; Tamagno I; Fornari A; Martinoglio B; Medico E; Zamò A; Facchetti F; Ponzoni M; Geissinger E; Rosenwald A; Müller-Hermelink HK; De Wolf-Peeters C; Piccaluga PP; Pileri S; Neri A; Inghirami G.
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
2010 Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merlio JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML.
Peripheral T cell lymphomas: a new frontier.
2010 Pileri S.; Agostinelli C.; Piccaluga P.P.
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET.
2010 Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P.; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G.
Pathobiology of anaplastic large cell lymphoma.
2010 Piccaluga PP; Gazzola A; Mannu C; Agostinelli C; Bacci F; Sabattini E; Sagramoso C; Piva R; Roncolato F; Inghirami G; Pileri SA.
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL
2010 Giebel S; Stella-Holowiecka B; Krawczyk-Kulis M; Gökbuget N; Hoelzer D; Doubek M; Mayer J; Piatkowska-Jakubas B; Skotnicki AB; Dombret H; Ribera JM; Piccaluga PP; Czerw T; Kyrcz-Krzemien S; Holowiecki J.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. | Gazzola A; Bertuzzi C; Agostinelli C; Righi S; Pileri SA; Piccaluga PP. | 2009-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. | Piccaluga PP; Sabattini E; Bacci F; Agostinelli C; Righi S; Salmi F; Testoni N; Paolini S; Castag...netti F; Martinelli G; Falini B; Pileri SA. | 2009-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. | Piccaluga P.P.; Rossi M.; De Falco G.; Esposito A.; Tazzari P.L.; Ricci F.; Agostinelli C.; Righi... S.; Gazzola A.; Went P.; Alviano F.; Luzzi A.; Morettini F.; Bagnara G.P.; Lazi S.; Zinzani P.L.; Lorenzo L.; Pileri S.A. | 2009-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified | Gazzola A.; Sista M.T.; Agostinelli C.; Righi S.; Sapienza M.R.; Mannu C.; Rossi M.; Bacci F.; SA...battini E.; Went P.; Zinzani P.L.; Pileri S.A.; Piccaluga P.P. | 2010-01-01 | PATHOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Chronic inflammation, including Autoimmunity, and Lymphomagenesis. | Pileri S.A.; Agostinelli C.; Campidelli C.; Bacci F.; Sabattini E.; Giunti M.; Pileri A. Jr.; Pic...cioli M.; Righi S.; Rossi M.; Ferri C.; Piccaluga P.P. | 2010-01-01 | - | Hodder Headline Group | 2.01 Capitolo / saggio in libro | - |
| Prognostic markers in peripheral T-cell lymphoma. | Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA. | 2010-01-01 | CURRENT HEMATOLOGIC MALIGNANCY REPORTS | - | 1.01 Articolo in rivista | - |
| Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. | Tripodo C; Gri G; Piccaluga PP; Frossi B; Guarnotta C; Piconese S; Franco G; Vetri V; Pucillo CE;... Florena AM; Colombo MP; Pileri SA. | 2010-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients. | Visani G; Breccia M; Gozzini A; Specchia G; Montefusco E; Morra E; Annunziata M; Camera A; Cavazz...ini F; Stagno F; Pregno P; Usala E; Santini V; Piccaluga PP; Isidori A. | 2010-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. | Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Maraf...ioti T; Bettini G; Falini B; Pileri SA. | 2010-01-01 | APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY | - | 1.01 Articolo in rivista | - |
| Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. | Piccaluga P.P.; Agostinelli C.; Gazzola A.; Sista M.T.; Righi S.; Bacci F.; Sabattini E.; Rossi M....; Mannu C.; Went P.; Zinzani P.L.; Pileri S.A. | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. | Mannu C.; Sagramoso C.; Gazzola A.; Rossi M.; Sapienza M.R.; La ginestra A.; Bacci F.; Sabattini ...E.; Agostinelli C.; Artioli P.; Chili L.; Da Pozzo G.; Piccioli M.; Righi S.; Sandri F.; Pileri S.A.; Piccaluga P.P. | 2010-01-01 | PATHOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms. | Agostinelli C.; Patterson J.C.; Gupta R.; Righi S.; Sandri F.; Piccaluga P.P.; Bacci F.; Sabattin...i E.; Pileri S.A.; Marafioti T. | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Pathobiology of Hodgkin Lymphoma. | P. Piccaluga; SA. Pileri. | 2010-01-01 | - | Gruppo Editoriale L’Espresso | 3.01 Monografia / trattato scientifico in forma di libro | - |
| IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES | M. Ciccone; C. Agostinelli; G. Rigolin; L. Rizzotto; F. Cavazzini; S. Righi; M.T. Sista; E. Sabat...tini; O. Sofritti; P.P. Piccaluga; A. Cuneo; S. Pileri; P.L. Zinzani; M. Brugiatelli; I. Attolico; G. Fioritono; C. Stilitano | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. | Piva R; Agnelli L; Pellegrino E; Todoerti K; Grosso V; Tamagno I; Fornari A; Martinoglio B; Medic...o E; Zamò A; Facchetti F; Ponzoni M; Geissinger E; Rosenwald A; Müller-Hermelink HK; De Wolf-Peeters C; Piccaluga PP; Pileri S; Neri A; Inghirami G. | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. | Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merl...io JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML. | 2010-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Peripheral T cell lymphomas: a new frontier. | Pileri S.; Agostinelli C.; Piccaluga P.P. | 2010-01-01 | VIRCHOWS ARCHIV | - | 4.02 Riassunto (Abstract) | - |
| Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. | Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P....; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G. | 2010-01-01 | MOLECULAR IMAGING AND BIOLOGY | - | 1.01 Articolo in rivista | - |
| Pathobiology of anaplastic large cell lymphoma. | Piccaluga PP; Gazzola A; Mannu C; Agostinelli C; Bacci F; Sabattini E; Sagramoso C; Piva R; Ronco...lato F; Inghirami G; Pileri SA. | 2010-01-01 | ADVANCES IN HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL | Giebel S; Stella-Holowiecka B; Krawczyk-Kulis M; Gökbuget N; Hoelzer D; Doubek M; Mayer J; Piatko...wska-Jakubas B; Skotnicki AB; Dombret H; Ribera JM; Piccaluga PP; Czerw T; Kyrcz-Krzemien S; Holowiecki J. | 2010-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile